Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.

ABSTRACT:

SUBMITTER: Folegatti PM 

PROVIDER: S-EPMC7172901 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature